文献速递冠心病

STEMI患者急诊PCI中联合血栓抽吸对临床事件的影响

[Effect of thrombus aspiration during primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction].
PubMed 文献 · Zhonghua Xin Xue Guan Bing Za Zhi · 2019-01-01

该回顾性研究纳入321例接受急诊PCI的STEMI患者,比较单纯PCI组(189例)与联合血栓抽吸组(132例)。联合抽吸组术后TIMI 3级血流比例更高(70.5%比60.8%,P=0.003),但主要终点事件发生率与单纯PCI组相似(17.1%比16.9%,P=0.962),再发心绞痛更常见(25.6%比16.3%,P=0.044)。

要点

  • 联合血栓抽吸未降低STEMI患者急诊PCI后的主要终点事件发生率。
  • 联合抽吸组术后TIMI 3级血流比例更高,但再发心绞痛更常见。
  • 病变血管数是PCI术后冠状动脉血运重建和主要终点事件的危险因素。

核心结论

  • STEMI患者接受急诊PCI联合血栓抽吸与单纯PCI相比,临床事件发生率相似。

研究设计与样本

  • 回顾性研究,纳入2013年1月至2014年3月在北京朝阳医院行急诊PCI的STEMI患者321例,分为单纯PCI组189例和联合血栓抽吸组132例。

主要发现

  • 联合抽吸组病变血管数多于单纯PCI组(1.59±0.81支比1.47±0.70支,P=0.039),梗死相关动脉为左前降支比例更高(52.3%比38.6%,P=0.022)。
  • 联合抽吸组症状发作时间(3.0(2.0,4.8)h比4.0(2.0,7.0)h,P=0.027)和心肌缺血时间(3.9(2.7,6.2)h比4.7(2.9,7.9)h,P=0.022)均短于单纯PCI组。
  • 联合抽吸组血栓TIMI分级≥4级比例(92.4%比75.1%,P<0.001)和术后TIMI 3级血流比例(70.5%比60.8%,P=0.003)均高于单纯PCI组。
  • 随访期间两组主要终点事件发生率差异无统计学意义(17.1%比16.9%,P=0.962),联合抽吸组再发心绞痛发生率更高(25.6%比16.3%,P=0.044)。
  • 多因素Cox回归显示病变血管数(RR=1.901,95%CI 1.217~2.970,P=0.005)和术后TIMI分级(RR=0.455,95%CI 0.221~0.934,P=0.032)是冠状动脉血运重建的危险因素,病变血管数(RR=1.421,95%CI 1.017~1.986,P=0.040)是主要终点事件的危险因素。

临床怎么用

  • 对于STEMI患者行急诊PCI,联合血栓抽吸可改善术后TIMI血流,但未减少主要临床事件,需个体化权衡。
  • 病变血管数和术后TIMI血流分级有助于评估PCI术后血运重建和主要事件风险。

局限性

  • 本研究为单中心回顾性研究,样本量有限,结果需前瞻性研究进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the effect of thrombus aspiration during primary percutaneous coronary intervention (PPCI) in patients with ST-segment elevation myocardial infarction (STEMI). Methods: This retrospective study included 321 STEMI patients who underwent PPCI at Beijing Chaoyang hospital from January 2013 to March 2014. Patients were divided into the PPCI group (189 cases) and the PPCI plus thrombus aspiration group (132 cases). Baseline and perioperative clinical data, procedural characteristics were collected, and primary endpoint events including all-cause death, re-myocardial infarction, and coronary revascularization and secondary endpoint events including cardiac death, recurrent angina, target lesion revascularization, and stent thrombosis were recorded during the follow-up. Results: There were no significant difference between PPCI group and PPCI plus aspiration group in age ((59.8±12.5) years old vs. (58.3±14.4) years old, P=0.060) and male ratio (82.5% (156/189) vs. 82.6% (109/132), P=0.993). The number of disease vessels (1.59±0.81 vs. 1.47±0.70, P=0.039) and the prevalence of left anterior descending as infarction related artery (52.3% (69/132) vs. 38.6% (73/189), P=0.022) were significantly higher in the PPCI plus aspiration group than that in the PPCI group.The symptom onset time (3.0 (2.0,4.8) hours vs. 4.0 (2.0,7.0) hours, P=0.027) and myocardial ischemia time (3.9 (2.7,6.2) hours vs. 4.7 (2.9,7.9) hours, P=0.022) were significantly in the PPCI plus aspiration group than in the PPCI group. The percent of thrombolysis in myocardial infarction (TIMI) thrombosis score≥ grade 4 (92.4% (122/132) vs. 75.1% (142/189), P<0.001)and postoperative TIMI flow grade 3 (70.5% (93/132) vs. 60.8% (115/189), P=0.003) was significantly higher in the PPCI plus aspiration group than in the PPCI group. The PPCI group patients were followed up for (31.6±7.5) months, and PPCI plus aspiration group patients were followed up for (32.2±6.7) months (P=0.466). During the follow-up period, there was no significant difference in the incidence of primary endpoint events between the PPCI plus aspiration group and the PPCI group (17.1% (22/129) vs. 16.9% (31/184), P=0.962). Recurrent angina was more frequent in the PPCI plus aspiration group than in the PPCI group (25.6% (33/129) vs. 16.3% (30/184), P=0.044). There was no significant difference in cardiac death (3.1% (4/129) vs. 3.3% (6/184), P=1.000), target lesion revascularization (3.9% (5/129) vs. 3.3% (6/184), P=0.765), and stent thrombosis (3.1% (4/129) vs. 2.7% (5/184), P=1.000) between the PPCI plus aspiration group and the PPCI group. Multivariate Cox regression analysis showed that the number of diseased vessels (RR=1.901, 95%CI 1.217-2.970, P=0.005) and postoperative TIMI flow grade (RR=0.455, 95%CI 0.221-0.934, P=0.032) were the risk factors for coronary revascularization after PPCI. The number of diseased vessels was a risk factor for major endpoint events after PPCI (RR=1.421, 95%CI 1.017-1.986, P=0.040). Conclusion: The incidence of clinical events is similar in patients with STEMI treated with PPCI alone or PPCI plus aspiration. 目的: 探讨联合血栓抽吸在ST段抬高型心肌梗死(STEMI)患者急诊经皮冠状动脉介入治疗(PPCI)中应用的效果。方法: 采用回顾性研究方法,纳入2013年1月至2014年3月在首都医科大学附属北京朝阳医院行PPCI的STEMI患者321例。根据介入治疗是否联合血栓抽吸,将入选患者分为PPCI组(189例)和联合血栓抽吸组(132例)。收集患者基本资料、PPCI术中和围手术期资料,记录术后主要终点事件(包括全因死亡、再次心肌梗死和冠状动脉血运重建)和次要终点事件(包括心原性死亡、再发心绞痛、靶病变血运重建和支架内血栓形成)的发生情况。结果: PPCI组与联合血栓抽吸组的年龄[(59.8±12.5)岁比(58.3±14.4)岁,P=0.060]和男性比例[82.5%(156/189)比82.6%(109/132),P=0.993]差异均无统计学意义。联合血栓抽吸组患者的病变血管数多于PPCI组[(1.59±0.81)支比(1.47±0.70)支,P=0.039],梗死相关动脉为左前降支的比例高于PPCI组[52.3%(69/132)比38.6%(73/189),P=0.022],症状发作时间[3.0(2.0,4.8)h比4.0(2.0,7.0)h,P=0.027]和心肌缺血时间[3.9(2.7,6.2)h比4.7(2.9,7.9)h,P=0.022]均短于PPCI组,血栓心肌梗死溶栓试验(TIMI)分级≥ 4级[92.4%(122/132)比75.1%(142/189),P<0.001]和术后血流TIMI分级为3级[70.5%(93/132)比60.8%(115/189),P=0.003]的比例均高于PPCI组。PPCI组随访时间为(31.6±7.5)个月,联合血栓抽吸组随访时间为(32.2±6.7)个月(P=0.466)。PPCI组与联合血栓抽吸组术后主要终点事件发生率差异无统计学意义[17.1%(22/129)比16.9%(31/184),P=0.962]。联合血栓抽吸组术后再发心绞痛发生率高于PPCI组[25.6%(33/129)比16.3%(30/184),P=0.044];联合血栓抽吸组与PPCI组术后心原性死亡[3.1%(4/129)比3.3%(6/184),P=1.000]、靶病变血运重建[3.9%(5/129)比3.3%(6/184),P=0.765]和支架血栓形成[3.1%(4/129)比2.7%(5/184),P=1.000]差异均无统计学意义。多因素Cox回归分析显示,冠状动脉病变血管数(RR=1.901,95%CI 1.217~2.970,P=0.005)和术后血流TIMI分级(RR=0.455,95%CI 0.221~0.934,P=0.032)是PPCI术后发生冠状动脉血运重建事件的危险因素,冠状动脉病变血管数是PPCI术后发生主要终点事件的危险因素(RR=1.421,95%CI 1.017~1.986,P=0.040)。结论: STEMI患者接受PPCI联合血栓抽吸和单纯PPCI治疗后,临床事件发生率相似。.

来源:Zhonghua Xin Xue Guan Bing Za Zhi,查看原文。版权归原作者所有。

引用

  1. Shen C, Wang LF. [Effect of thrombus aspiration during primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction]. Zhonghua Xin Xue Guan Bing Za Zhi. 2019. PMID: 30669810. doi:10.3760/cma.j.issn.0253-3758.2019.01.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。